2021 Amendments to Chinese patent law—What’s in it for the life sciences?

Presented by

Keith Haddaway (Venable)

About this talk

Amendments to Chinese patent law went into effect on June 1, 2021. Some of these amendments have important consequences for life sciences patent practice in China. The most striking change is the establishment of a system for resolving patent disputes in the life sciences. While similar to the Hatch-Waxman process, the Chinese law also encompasses biologics and traditional Chinese medicines in addition to small-chemical drugs. Amendments are also directed at extensions of patent terms under particular circumstances. This presentation will include a description of the new Chinese system and a comparison to the US system.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (70)
Subscribers (10331)
Content for the home of World IP Review and Life Sciences IP Review